What is the current Price Target for the Bio-Path Holdings, Inc. stock?

The average Bio-Path Holdings, Inc. target price is $2.04. This is 2,242.14% higher than the current stock price. The highest price target is 2,311.02%, the lowest is 2,219.17%. 3 Analysts have issued a price target Bio-Path Holdings, Inc. 2026 .

How high will the Bio-Path Holdings, Inc. stock rise?

No reliable answer can be given as to how high the Bio-Path Holdings, Inc. stock will rise. The performance of stocks, including the Bio-Path Holdings, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Bio-Path Holdings, Inc. stock today?

The performance of Bio-Path Holdings, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Bio-Path Holdings, Inc. stock fall?

The decline in Bio-Path Holdings, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Bio-Path Holdings, Inc. Forecast, price target & analysts

$0.09

0.00% yesterday

Nasdaq, Nov 07, 08:33 pm CET

ISIN

US09057N2018

Symbol

BPTH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Bio-Path Holdings, Inc. Target price 2025 - Analyst rating & recommendation

Bio-Path Holdings, Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Bio-Path Holdings, Inc. Price Target

Target Price	$2.04
Price	$0.09
Potential	2,242.14% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Bio-Path Holdings, Inc. 2026 . The average Bio-Path Holdings, Inc. target price is $2.04. This is 2,242.14% register free of charge higher than the current stock price. The highest price target is $2.10 2,311.02% register free of charge , the lowest is $2.02 2,219.17% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Bio-Path Holdings, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Bio-Path Holdings, Inc. stock has an average upside potential 2026 of 2,242.14% register free of charge . Most analysts recommend the Bio-Path Holdings, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-33.64	-3.23
	11.75%	90.40%
P/E		negative

3 Analysts have issued a Bio-Path Holdings, Inc. forecast for earnings per share. The average Bio-Path Holdings, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-33.64	11.75%
2024	$-3.23 90.40% Unlock
2025	$-1.62 49.85% Unlock
2026	$-1.45 10.49% Unlock
2027	$-1.40 3.45% Unlock

Current	-0.03	91.12%
2024	-0.03 20.00% Unlock
2025	-0.05 66.67% Unlock
2026	-0.06 20.00% Unlock
2027	-0.06 0.00% Unlock

Bio-Path Holdings, Inc....

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now